Previous close | 42.75 |
Open | 42.75 |
Bid | 41.20 |
Ask | 42.90 |
Strike | 110.00 |
Expiry date | 2025-01-17 |
Day's range | 42.75 - 42.75 |
Contract range | N/A |
Volume | |
Open interest | N/A |
While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.
Data from an early-stage study shows that patients who received Viking's (VKTX) orally-administered obesity drug lost up to 5.3% of their body weight after 28 days.
In the most recent trading session, Astrazeneca (AZN) closed at $66.33, indicating a +0.71% shift from the previous trading day.